Hilin-GM Tablet is a combination pharmaceutical formulation containing Diacerein 50 mg and Glucosamine 750 mg, primarily indicated for the management of osteoarthritis and related degenerative joint disorders. Diacerein, an anthraquinone derivative, exhibits anti-inflammatory and chondroprotective properties by inhibiting interleukin-1 beta (IL-1β), thereby reducing cartilage degradation and promoting joint function. Glucosamine, an amino monosaccharide, serves as a key substrate for the biosynthesis of glycosaminoglycans and proteoglycans, essential components of cartilage matrix, contributing to cartilage repair and maintenance. The synergistic effect of these active ingredients aids in alleviating joint pain, improving mobility, and slowing disease progression. Hilin-GM Tablet is typically administered orally, with dosage tailored to patient-specific clinical conditions and physician recommendations. It is contraindicated in individuals with hypersensitivity to either component, severe hepatic or renal impairment, and caution is advised in patients with gastrointestinal disorders. Common adverse effects may include mild gastrointestinal disturbances such as diarrhea, abdominal pain, and nausea. Regular monitoring and adherence to prescribed dosage are essential to optimize therapeutic outcomes. Hilin-GM Tablet should be used as part of a comprehensive treatment plan, including physical therapy and lifestyle modifications, under medical supervision.